有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(1R)-1-(2,6-difluorophenyl)ethyl]sulfanyl-6-methylpyrimidin-4-amine | —— | C13H13F2N3S |
|
—— | 2-[(1S)-1-(2,6-difluorophenyl)ethyl]sulfanyl-6-methylpyrimidin-4-amine | —— | C13H13F2N3S |
|
—— | (3S)-3-[[5-(furan-2-yl)-4-prop-2-enyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1-methylpiperidine | —— | C16H22N4OS |
|
—— | [(2S)-2,3-dihydro-1,4-benzoxathiin-2-yl]-[4-[(2R)-2-hydroxybutyl]piperazin-1-yl]methanone | —— | C17H24N2O3S |
|
—— | [(2R)-2,3-dihydro-1,4-benzoxathiin-2-yl]-[4-[(2S)-2-hydroxybutyl]piperazin-1-yl]methanone | —— | C17H24N2O3S |
|
—— | (2S)-N-[(E)-3-chloroprop-2-enyl]-N-methyl-1-methylsulfonylpropan-2-amine | —— | C8H16ClNO2S |
|
—— | [(2S)-2,3-dihydro-1,4-benzoxathiin-2-yl]-[4-[(2S)-2-hydroxybutyl]piperazin-1-yl]methanone | —— | C17H24N2O3S |
|
—— | [(2R)-2,3-dihydro-1,4-benzoxathiin-2-yl]-[4-[(2R)-2-hydroxybutyl]piperazin-1-yl]methanone | —— | C17H24N2O3S |
|
—— | (2R)-N-[(E)-3-chloroprop-2-enyl]-N-methyl-1-methylsulfonylpropan-2-amine | —— | C8H16ClNO2S |
|
—— | 2-[4,5-dimethyl-1-(2-methylpropyl)imidazol-2-yl]sulfanyl-N-(2-phenylsulfanylphenyl)acetamide | —— | C23H27N3OS2 |
|
—— | [(2R)-2,3-dihydro-1-benzothiophen-2-yl]-[(2R)-2-[(4-methylpyrazol-1-yl)methyl]pyrrolidin-1-yl]methanone | —— | C18H21N3OS |
|
—— | 2-[(1S)-2,2,2-trifluoro-1-phenylethyl]sulfanyl-1,3,4-thiadiazole | —— | C10H7F3N2S2 |
|
—— | [(2R)-2,3-dihydro-1-benzothiophen-2-yl]-[(2S)-2-[(4-methylpyrazol-1-yl)methyl]pyrrolidin-1-yl]methanone | —— | C18H21N3OS |
|
—— | [(2S)-2,3-dihydro-1-benzothiophen-2-yl]-[(2S)-2-[(4-methylpyrazol-1-yl)methyl]pyrrolidin-1-yl]methanone | —— | C18H21N3OS |
|
—— | 2-[(1R)-2,2,2-trifluoro-1-phenylethyl]sulfanyl-1,3,4-thiadiazole | —— | C10H7F3N2S2 |
|
—— | N-[(1S)-1-(4-ethylsulfanylphenyl)ethyl]-3-(1-methylpyrazol-4-yl)propanamide | —— | C17H23N3OS |
|
—— | [(2S)-2,3-dihydro-1-benzothiophen-2-yl]-[(2R)-2-[(4-methylpyrazol-1-yl)methyl]pyrrolidin-1-yl]methanone | —— | C18H21N3OS |
|
—— | N-[(S)-phenyl(1,3-thiazol-2-yl)methyl]-2-pyridin-2-ylsulfanylacetamide | —— | C17H15N3OS2 |
|
—— | N-[(R)-phenyl(1,3-thiazol-2-yl)methyl]-2-pyridin-2-ylsulfanylacetamide | —— | C17H15N3OS2 |
|
—— | N-[(1R)-1-(4-ethylsulfanylphenyl)ethyl]-3-(1-methylpyrazol-4-yl)propanamide | —— | C17H23N3OS |
|
—— | 2-(4-amino-6-methylpyrimidin-2-yl)sulfanyl-N-[(R)-cyclopropyl-(4-methylphenyl)methyl]acetamide | —— | C18H22N4OS |
|
—— | 2-[[5-oxo-4-(2-phenylethyl)-1H-1,2,4-triazol-3-yl]sulfanyl]-N-[(1R)-1-phenylbutyl]acetamide | —— | C22H26N4O2S |
|
—— | 2-[[5-oxo-4-(2-phenylethyl)-1H-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S)-1-phenylbutyl]acetamide | —— | C22H26N4O2S |
|
—— | N-[(1S)-1-(4-ethylsulfanylphenyl)ethyl]-3,4-dimethyl-6-oxo-1H-pyridazine-5-carboxamide | —— | C17H21N3O2S |
|
—— | N-methyl-N-[4-[[5-oxo-4-[[(2S)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3-thiazol-2-yl]acetamide | —— | C14H19N5O3S2 |
|
—— | [2-oxo-2-[[(1R)-1-phenylbutyl]amino]ethyl] 2-(2,4-dimethylphenyl)sulfanylacetate | —— | C22H27NO3S |
|
—— | [2-oxo-2-[[(1R)-1-phenylbutyl]amino]ethyl] 2-(3,4-dimethylphenyl)sulfanylacetate | —— | C22H27NO3S |
|
—— | 2-(3-bromophenyl)-5-[(1S)-1-(4-fluorophenyl)ethyl]sulfanyl-1,3,4-oxadiazole | —— | C16H12BrFN2OS |
|
—— | 2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(1S)-1-cyano-1-cyclopropylethyl]acetamide | —— | C16H15BrN4O2S |
|
—— | 2-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(1S)-1-phenylbutyl]acetamide | —— | C21H23N3O2S |
|
—— | 2-(3-Bromophenyl)-5-[(4-methylsulfanylphenyl)methylsulfanyl]-1,3,4-oxadiazole | —— | C16H13BrN2OS2 |
|
—— | 2-(3-bromophenyl)-5-[(1R)-1-(2-chlorophenyl)ethyl]sulfanyl-1,3,4-oxadiazole | —— | C16H12BrClN2OS |
|
—— | 2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(1R)-1-cyano-1-cyclopropylethyl]acetamide | —— | C16H15BrN4O2S |
|
—— | 2-(2-chlorophenyl)sulfanyl-1-[4-[[(2R)-oxolan-2-yl]methyl]piperazin-1-yl]ethanone | —— | C17H23ClN2O2S |
|
—— | 2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(2S)-1-methoxypropan-2-yl]acetamide | —— | C14H16BrN3O3S |
|
—— | [2-oxo-2-[[(1S)-1-phenylbutyl]amino]ethyl] 2-(3,4-dimethylphenyl)sulfanylacetate | —— | C22H27NO3S |
|
—— | 3-[[(3S)-1-methylpiperidin-3-yl]methylsulfanyl]-4-[[(2S)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C14H24N4O2S |
|
—— | 2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(1S)-1-phenylbutyl]acetamide | —— | C22H25N3O2S |
|
—— | 2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-cycloheptylacetamide | —— | C17H20BrN3O2S |
|
—— | 2-(3-Bromophenyl)-5-[(3-chlorophenyl)methylsulfanyl]-1,3,4-oxadiazole | —— | C15H10BrClN2OS |
|
—— | (2R)-2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-cyclopentylpropanamide | —— | C16H18BrN3O2S |
|
—— | 4-[[5-(3-Bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-2-ethanimidoyl-3-oxobutanenitrile | —— | C14H11BrN4O2S |
|
—— | 3-[[(3R)-1-methylpiperidin-3-yl]methylsulfanyl]-4-[[(2S)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C14H24N4O2S |
|
—— | 2-(3-Bromophenyl)-5-[(4-methylphenyl)methylsulfanyl]-1,3,4-oxadiazole | —— | C16H13BrN2OS |
|
—— | 2-(2-chlorophenyl)sulfanyl-1-[4-[[(2S)-oxolan-2-yl]methyl]piperazin-1-yl]ethanone | —— | C17H23ClN2O2S |
|
—— | (2S)-2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-cyclopentylpropanamide | —— | C16H18BrN3O2S |
|
—— | 2-(3-bromophenyl)-5-[(1S)-1-(2-chlorophenyl)ethyl]sulfanyl-1,3,4-oxadiazole | —— | C16H12BrClN2OS |
|
—— | 2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(1S)-1-phenylbutyl]acetamide | —— | C15H19N3OS2 |
|
—— | 4-[[5-(3-Bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-1-thiophen-2-ylbutan-1-one | —— | C16H13BrN2O2S2 |
|
—— | 2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-cyclopentylacetamide | —— | C15H16BrN3O2S |
|